SLC2A4 and Insulin resistance: In vitro studies demonstrated that the PI indinavir inhibits the activity of GLUT-4, an insulin-sensitive glucose transporter responsible for glucose uptake into muscle and fat cells, thereby contributing to insulin resistance [21, 22].